Cayman
Showing 25801–25950 of 45550 results
-
JWH 019 is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB) and the peripheral CB receptors.{16797} It has been detected in certain herbal blends sold for human consumption. JWH 019 5-hydroxyindole metabolite is expected to be a major metabolite of JWH 019, detectable in serum and urine.{18291,18292} The biological effects of the metabolite are not known
Brand:CaymanSKU:9000764 - 10 mgAvailable on backorder
JWH 019 is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB) and the peripheral CB receptors.{16797} It has been detected in certain herbal blends sold for human consumption. JWH 019 5-hydroxyindole metabolite is expected to be a major metabolite of JWH 019, detectable in serum and urine.{18291,18292} The biological effects of the metabolite are not known
Brand:CaymanSKU:9000764 - 5 mgAvailable on backorder
JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(5-hydroxyhexyl) metabolite is an expected urinary metabolite of JWH 019 that should be detectable both in serum and urine based on studies of the metabolism of the structurally similar compound, JWH 018.{18617,18291,19353,16797} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:- JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(5-hydroxyhexyl) metabolite is an expected urinary metabolite of JWH 019 that should be detectable both in serum and urine based on studies of the metabolism of the structurally similar compound, JWH 018.{18617,18291,19353,16797} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:- JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(5-hydroxyhexyl) metabolite is an expected urinary metabolite of JWH 019 that should be detectable both in serum and urine based on studies of the metabolism of the structurally similar compound, JWH 018.{18617,18291,19353,16797} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:-
Cannabimimetic indoles, including certain JWH compounds, have been identified in herbal blends. JWH 018, a potent agonist of both the central cannabinoid (CB1) receptor and peripheral cannabinoid (CB2) receptor, has been found in many herbal blends and has been regulated in the United States and other countries. Studies indicate that JWH 018 is rapidly metabolized by the liver and that certain metabolites can be identified in the urine.{18617,18291,19353} JWH 019 is nearly identical to JWH 018 in structure and activity at both CB receptors.{16797} JWH 019 N-(6-hydroxyhexyl) metabolite is an expected metabolite of JWH 019, detectable both in serum and urine. Its biological activities have not been evaluated.
Brand:CaymanSKU:9000765 - 1 mgAvailable on backorder
Cannabimimetic indoles, including certain JWH compounds, have been identified in herbal blends. JWH 018, a potent agonist of both the central cannabinoid (CB1) receptor and peripheral cannabinoid (CB2) receptor, has been found in many herbal blends and has been regulated in the United States and other countries. Studies indicate that JWH 018 is rapidly metabolized by the liver and that certain metabolites can be identified in the urine.{18617,18291,19353} JWH 019 is nearly identical to JWH 018 in structure and activity at both CB receptors.{16797} JWH 019 N-(6-hydroxyhexyl) metabolite is an expected metabolite of JWH 019, detectable both in serum and urine. Its biological activities have not been evaluated.
Brand:CaymanSKU:9000765 - 10 mgAvailable on backorder
Cannabimimetic indoles, including certain JWH compounds, have been identified in herbal blends. JWH 018, a potent agonist of both the central cannabinoid (CB1) receptor and peripheral cannabinoid (CB2) receptor, has been found in many herbal blends and has been regulated in the United States and other countries. Studies indicate that JWH 018 is rapidly metabolized by the liver and that certain metabolites can be identified in the urine.{18617,18291,19353} JWH 019 is nearly identical to JWH 018 in structure and activity at both CB receptors.{16797} JWH 019 N-(6-hydroxyhexyl) metabolite is an expected metabolite of JWH 019, detectable both in serum and urine. Its biological activities have not been evaluated.
Brand:CaymanSKU:9000765 - 5 mgAvailable on backorder
JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide is an expected major urinary metabolite of JWH 019, based on the metabolism of similar cannabimimetics.{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:11466 - 1 mgAvailable on backorder
JWH 019 (Item No. 13633) is a cannabimimetic indole that shows a high-affinity for both the central cannabinoid (CB1) (Ki = 9.8 nM) and the peripheral cannabinoid (CB2) (Ki = 5.6 nM) receptors.{16797} JWH 019 N-(6-hydroxyhexyl) β-D-Glucuronide is an expected major urinary metabolite of JWH 019, based on the metabolism of similar cannabimimetics.{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:11466 - 500 µgAvailable on backorder
JWH 020 is a cannabimimetic indole derived from WIN 55,212-1. Its affinities for the cannabinoid (CB) receptors CB1 and CB2 (128 and 205 nM, respectively) are significantly weaker than those of WIN 55,212-2 (1.89 and 0.28 nM, respectively).{16797} The effects of JWH 020 in vivo have not been explored.
Brand:CaymanSKU:10850 - 10 mgAvailable on backorder
JWH 020 is a cannabimimetic indole derived from WIN 55,212-1. Its affinities for the cannabinoid (CB) receptors CB1 and CB2 (128 and 205 nM, respectively) are significantly weaker than those of WIN 55,212-2 (1.89 and 0.28 nM, respectively).{16797} The effects of JWH 020 in vivo have not been explored.
Brand:CaymanSKU:10850 - 25 mgAvailable on backorder
JWH 020 is a cannabimimetic indole derived from WIN 55,212-1. Its affinities for the cannabinoid (CB) receptors CB1 and CB2 (128 and 205 nM, respectively) are significantly weaker than those of WIN 55,212-2 (1.89 and 0.28 nM, respectively).{16797} The effects of JWH 020 in vivo have not been explored.
Brand:CaymanSKU:10850 - 5 mgAvailable on backorder
JWH 022 is a cannabimimetic indole that is structurally related to JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB2) receptor.{18291} The biological activity of JWH 022 has not been reported.
Brand:CaymanSKU:9001056 - 1 mgAvailable on backorder
JWH 022 is a cannabimimetic indole that is structurally related to JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB2) receptor.{18291} The biological activity of JWH 022 has not been reported.
Brand:CaymanSKU:9001056 - 10 mgAvailable on backorder
JWH 022 is a cannabimimetic indole that is structurally related to JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB2) receptor.{18291} The biological activity of JWH 022 has not been reported.
Brand:CaymanSKU:9001056 - 25 mgAvailable on backorder
JWH 022 is a cannabimimetic indole that is structurally related to JWH 018, a mildly selective agonist of the peripheral cannabinoid (CB2) receptor.{18291} The biological activity of JWH 022 has not been reported.
Brand:CaymanSKU:9001056 - 5 mgAvailable on backorder
JWH 030 is a naphthoyl pyrrole cannabimimetic which activates the CB1 receptor (EC50 = 30.5 nM for rat, Ki = 87 nM for mouse) better than CB2 (EC50 = 552 nM for human CB2).{11496,20068} JWH 030 is quite potent in vivo in the mouse spontaneous activity and tail flick (antinociception) assays (ED50 = 26.8 μM/kg).{20068} It also dose-dependently inhibits electrically-induced contractions of the mouse vas deferens (IC50 = 3.38 nM).{20069} This product is intended for forensic or research purposes.
Brand:CaymanSKU:10831 - 1 mgAvailable on backorder
JWH 030 is a naphthoyl pyrrole cannabimimetic which activates the CB1 receptor (EC50 = 30.5 nM for rat, Ki = 87 nM for mouse) better than CB2 (EC50 = 552 nM for human CB2).{11496,20068} JWH 030 is quite potent in vivo in the mouse spontaneous activity and tail flick (antinociception) assays (ED50 = 26.8 μM/kg).{20068} It also dose-dependently inhibits electrically-induced contractions of the mouse vas deferens (IC50 = 3.38 nM).{20069} This product is intended for forensic or research purposes.
Brand:CaymanSKU:10831 - 10 mgAvailable on backorder
JWH 030 is a naphthoyl pyrrole cannabimimetic which activates the CB1 receptor (EC50 = 30.5 nM for rat, Ki = 87 nM for mouse) better than CB2 (EC50 = 552 nM for human CB2).{11496,20068} JWH 030 is quite potent in vivo in the mouse spontaneous activity and tail flick (antinociception) assays (ED50 = 26.8 μM/kg).{20068} It also dose-dependently inhibits electrically-induced contractions of the mouse vas deferens (IC50 = 3.38 nM).{20069} This product is intended for forensic or research purposes.
Brand:CaymanSKU:10831 - 25 mgAvailable on backorder
JWH 030 is a naphthoyl pyrrole cannabimimetic which activates the CB1 receptor (EC50 = 30.5 nM for rat, Ki = 87 nM for mouse) better than CB2 (EC50 = 552 nM for human CB2).{11496,20068} JWH 030 is quite potent in vivo in the mouse spontaneous activity and tail flick (antinociception) assays (ED50 = 26.8 μM/kg).{20068} It also dose-dependently inhibits electrically-induced contractions of the mouse vas deferens (IC50 = 3.38 nM).{20069} This product is intended for forensic or research purposes.
Brand:CaymanSKU:10831 - 5 mgAvailable on backorder
JWH 031 is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM).{16798} Despite its low affinity for CB1, this pyrrole-based cannabinoid is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} This product is intended for forensic and research applications.
Brand:CaymanSKU:10824 - 10 mgAvailable on backorder
JWH 031 is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM).{16798} Despite its low affinity for CB1, this pyrrole-based cannabinoid is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} This product is intended for forensic and research applications.
Brand:CaymanSKU:10824 - 25 mgAvailable on backorder
JWH 031 is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM).{16798} Despite its low affinity for CB1, this pyrrole-based cannabinoid is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} This product is intended for forensic and research applications.
Brand:CaymanSKU:10824 - 5 mgAvailable on backorder
JWH 031 (Item No. 10824) is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM) that is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} JWH 031 2’-isomer differs from JWH 031 by having the naphthyl group at the 2’ position, rather than the 5’ position, of the pyrrole group. The physiological properties of this compound are unknown. This product is intended for forensic and research purposes.
Brand:CaymanSKU:11631 - 1 mgAvailable on backorder
JWH 031 (Item No. 10824) is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM) that is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} JWH 031 2’-isomer differs from JWH 031 by having the naphthyl group at the 2’ position, rather than the 5’ position, of the pyrrole group. The physiological properties of this compound are unknown. This product is intended for forensic and research purposes.
Brand:CaymanSKU:11631 - 10 mgAvailable on backorder
JWH 031 (Item No. 10824) is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM) that is efficacious in reducing spontaneous activity and increasing antinociception in mice.{16798} JWH 031 2’-isomer differs from JWH 031 by having the naphthyl group at the 2’ position, rather than the 5’ position, of the pyrrole group. The physiological properties of this compound are unknown. This product is intended for forensic and research purposes.
Brand:CaymanSKU:11631 - 5 mgAvailable on backorder
JWH 071 is a synthetic cannabinoid (CB) which binds the central CB1 receptor (Ki = 1340 nM) with higher affinity than the peripheral CB2 receptor (Ki = 2940 nM).{16797,16798} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:- JWH 071 is a synthetic cannabinoid (CB) which binds the central CB1 receptor (Ki = 1340 nM) with higher affinity than the peripheral CB2 receptor (Ki = 2940 nM).{16797,16798} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:- JWH 071 is a synthetic cannabinoid (CB) which binds the central CB1 receptor (Ki = 1340 nM) with higher affinity than the peripheral CB2 receptor (Ki = 2940 nM).{16797,16798} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:- JWH 071 is a synthetic cannabinoid (CB) which binds the central CB1 receptor (Ki = 1340 nM) with higher affinity than the peripheral CB2 receptor (Ki = 2940 nM).{16797,16798} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:-
JWH 072 is a synthetic cannabinoid (CB) that displays a higher affinity for the peripheral CB2 receptor (Ki = 170 nM) than the central CB1 receptor (Ki = 1,050 nM).{16797,18232} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:9001201 - 10 mgAvailable on backorder
JWH 072 is a synthetic cannabinoid (CB) that displays a higher affinity for the peripheral CB2 receptor (Ki = 170 nM) than the central CB1 receptor (Ki = 1,050 nM).{16797,18232} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:9001201 - 25 mgAvailable on backorder
JWH 072 is a synthetic cannabinoid (CB) that displays a higher affinity for the peripheral CB2 receptor (Ki = 170 nM) than the central CB1 receptor (Ki = 1,050 nM).{16797,18232} The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.
Brand:CaymanSKU:9001201 - 5 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} Its effects on suppression of spontaneous activity, maximum possible antinociceptive effect in the tail-flick assay, and rectal temperature are comparable to those of WIN 55,212-2 when tested in rats.{16798}
Brand:CaymanSKU:- JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} Its effects on suppression of spontaneous activity, maximum possible antinociceptive effect in the tail-flick assay, and rectal temperature are comparable to those of WIN 55,212-2 when tested in rats.{16798}
Brand:CaymanSKU:- JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} Its effects on suppression of spontaneous activity, maximum possible antinociceptive effect in the tail-flick assay, and rectal temperature are comparable to those of WIN 55,212-2 when tested in rats.{16798}
Brand:CaymanSKU:-
JWH 073 2-hydroxyindole metabolite is a potential monohydroxylated urinary metabolite of JWH 073, a WIN 55,212-2 derivative that is a mildly selective agonist of the peripheral cannabinoid receptor.
Brand:CaymanSKU:10633 - 1 mgAvailable on backorder
JWH 073 2-hydroxyindole metabolite is a potential monohydroxylated urinary metabolite of JWH 073, a WIN 55,212-2 derivative that is a mildly selective agonist of the peripheral cannabinoid receptor.
Brand:CaymanSKU:10633 - 10 mgAvailable on backorder
JWH 073 2-hydroxyindole metabolite is a potential monohydroxylated urinary metabolite of JWH 073, a WIN 55,212-2 derivative that is a mildly selective agonist of the peripheral cannabinoid receptor.
Brand:CaymanSKU:10633 - 5 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the CB1 and the CB2 receptor (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been identified in herbal blends.{19508,18621,18334} JWH 073 2-methylnaphthyl analog differs structurally from JWH 073 by having a methyl group added at the 2 position of the naphthyl moiety. The biological and toxicological properties of this compound have not been characterized. This compound is intended for forensic and research purposes.
Brand:CaymanSKU:10848 - 1 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the CB1 and the CB2 receptor (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been identified in herbal blends.{19508,18621,18334} JWH 073 2-methylnaphthyl analog differs structurally from JWH 073 by having a methyl group added at the 2 position of the naphthyl moiety. The biological and toxicological properties of this compound have not been characterized. This compound is intended for forensic and research purposes.
Brand:CaymanSKU:10848 - 10 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the CB1 and the CB2 receptor (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been identified in herbal blends.{19508,18621,18334} JWH 073 2-methylnaphthyl analog differs structurally from JWH 073 by having a methyl group added at the 2 position of the naphthyl moiety. The biological and toxicological properties of this compound have not been characterized. This compound is intended for forensic and research purposes.
Brand:CaymanSKU:10848 - 5 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 4-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000861 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 4-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000861 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 4-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000861 - 5 mgAvailable on backorder
JWH 073 is a cannabimimetic aminoalkylindole which has been identified in herbal incense.{19508} JWH 073 4-methyl naphthyl analog differs structurally from JWH 073 by having a methyl group added at the 4 position of the naphthyl rings. While the effect of this modification to JWH 073 has not been evaluated, the similar addition to JWH 018 produces JWH 122, which has higher affinities for both central cannabinoid (CB1) (Ki = 9.0 and 0.69, respectively) and peripheral cannabinoid (CB2) receptors (Ki = 2.9 and 1.2, respectively).{18232} This product is intended for forensic and research purposes only.
Brand:CaymanSKU:9001076 - 1 mgAvailable on backorder
JWH 073 is a cannabimimetic aminoalkylindole which has been identified in herbal incense.{19508} JWH 073 4-methyl naphthyl analog differs structurally from JWH 073 by having a methyl group added at the 4 position of the naphthyl rings. While the effect of this modification to JWH 073 has not been evaluated, the similar addition to JWH 018 produces JWH 122, which has higher affinities for both central cannabinoid (CB1) (Ki = 9.0 and 0.69, respectively) and peripheral cannabinoid (CB2) receptors (Ki = 2.9 and 1.2, respectively).{18232} This product is intended for forensic and research purposes only.
Brand:CaymanSKU:9001076 - 10 mgAvailable on backorder
JWH 073 is a cannabimimetic aminoalkylindole which has been identified in herbal incense.{19508} JWH 073 4-methyl naphthyl analog differs structurally from JWH 073 by having a methyl group added at the 4 position of the naphthyl rings. While the effect of this modification to JWH 073 has not been evaluated, the similar addition to JWH 018 produces JWH 122, which has higher affinities for both central cannabinoid (CB1) (Ki = 9.0 and 0.69, respectively) and peripheral cannabinoid (CB2) receptors (Ki = 2.9 and 1.2, respectively).{18232} This product is intended for forensic and research purposes only.
Brand:CaymanSKU:9001076 - 5 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000862 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000862 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000862 - 5 mgAvailable on backorder
JWH 073 5-hydroxyindole metabolite-d7 contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4 positions. It is intended for use as an internal standard for the quantification of JWH 073 5-hydroxyindole metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:10718 - 1 mgAvailable on backorder
JWH 073 5-hydroxyindole metabolite-d7 contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4 positions. It is intended for use as an internal standard for the quantification of JWH 073 5-hydroxyindole metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:10718 - 100 µgAvailable on backorder
JWH 073 5-hydroxyindole metabolite-d7 contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4 positions. It is intended for use as an internal standard for the quantification of JWH 073 5-hydroxyindole metabolite by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 5-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:10718 - 500 µgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic cannabinoids which have been included in smoking mixtures. JWH 073 6-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000863 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic cannabinoids which have been included in smoking mixtures. JWH 073 6-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000863 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic cannabinoids which have been included in smoking mixtures. JWH 073 6-hydroxyindole metabolite is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000863 - 5 mgAvailable on backorder
JWH 073 (Item No. 10904) is a potent synthetic cannabinoid (CB) which has been found in herbal mixtures.{16797,19508} JWH 073 6-methoxyindole analog is an analog of JWH 073 and is also structurally similar to a primary metabolite of the CB, JWH 073 6-hydroxyindole metabolite (Item No. 9000863). The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:- JWH 073 (Item No. 10904) is a potent synthetic cannabinoid (CB) which has been found in herbal mixtures.{16797,19508} JWH 073 6-methoxyindole analog is an analog of JWH 073 and is also structurally similar to a primary metabolite of the CB, JWH 073 6-hydroxyindole metabolite (Item No. 9000863). The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:- JWH 073 (Item No. 10904) is a potent synthetic cannabinoid (CB) which has been found in herbal mixtures.{16797,19508} JWH 073 6-methoxyindole analog is an analog of JWH 073 and is also structurally similar to a primary metabolite of the CB, JWH 073 6-hydroxyindole metabolite (Item No. 9000863). The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic applications.
Brand:CaymanSKU:-
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 7-hydroxyindole metabolite, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000864 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 7-hydroxyindole metabolite, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000864 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 7-hydroxyindole metabolite, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000864 - 5 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the central CB1 and peripheral CB2 receptors (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been found in herbal blends.{19508,18621,18334} JWH 073 N-(2-methylpropyl) isomer differs structurally from JWH 073 by having a methylpropyl group, rather than a butyl chain, extending from the indole group. The biological activities of this compound have not been characterized.
Brand:CaymanSKU:9001011 - 1 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the central CB1 and peripheral CB2 receptors (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been found in herbal blends.{19508,18621,18334} JWH 073 N-(2-methylpropyl) isomer differs structurally from JWH 073 by having a methylpropyl group, rather than a butyl chain, extending from the indole group. The biological activities of this compound have not been characterized.
Brand:CaymanSKU:9001011 - 10 mgAvailable on backorder
JWH 073 is a synthetic cannabinoid (CB) that activates both the central CB1 and peripheral CB2 receptors (Ki = 8.9 and 38 nM, respectively).{16797} This cannabimimetic compound has been found in herbal blends.{19508,18621,18334} JWH 073 N-(2-methylpropyl) isomer differs structurally from JWH 073 by having a methylpropyl group, rather than a butyl chain, extending from the indole group. The biological activities of this compound have not been characterized.
Brand:CaymanSKU:9001011 - 5 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) metabolite is expected to be a major urinary metabolite of JWH 073, characterized by monohydroxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000865 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) metabolite is expected to be a major urinary metabolite of JWH 073, characterized by monohydroxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000865 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) metabolite is expected to be a major urinary metabolite of JWH 073, characterized by monohydroxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000865 - 5 mgAvailable on backorder
JWH 073 (Item No. 14237) is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral CB2 receptor are 8.9 and 38 nM, respectively, for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 (Item No. 10009018) and JWH 018 (Item No. 10900).{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:11464 - 1 mgAvailable on backorder
JWH 073 (Item No. 14237) is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral CB2 receptor are 8.9 and 38 nM, respectively, for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) β-D-Glucuronide is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 (Item No. 10009018) and JWH 018 (Item No. 10900).{18291,19353,20170} The physiological and toxicological properties of this compound have not been tested. This product is intended for forensic and research applications.
Brand:CaymanSKU:11464 - 500 µgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-butanoic acid metabolite is expected to be a urinary metabolite of JWH 073, characterized by carboxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000866 - 1 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-butanoic acid metabolite is expected to be a urinary metabolite of JWH 073, characterized by carboxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000866 - 10 mgAvailable on backorder
JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-butanoic acid metabolite is expected to be a urinary metabolite of JWH 073, characterized by carboxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}
Brand:CaymanSKU:9000866 - 5 mgAvailable on backorder
JWH 073 N-butanoic acid metabolite 6-d5 contains five deuterium atoms at the 2, 4 ,5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of JWH 073 N-butanoic acid metabolite by GC- or LC-mass spectrometry (MS). JWH 073 N-butanoic acid metabolite, characterized by carboxylation of the N-alkyl chain, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000870 - 1 mgAvailable on backorder
JWH 073 N-butanoic acid metabolite 6-d5 contains five deuterium atoms at the 2, 4 ,5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of JWH 073 N-butanoic acid metabolite by GC- or LC-mass spectrometry (MS). JWH 073 N-butanoic acid metabolite, characterized by carboxylation of the N-alkyl chain, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000870 - 100 µgAvailable on backorder
JWH 073 N-butanoic acid metabolite 6-d5 contains five deuterium atoms at the 2, 4 ,5, 6, and 7 positions. It is intended for use as an internal standard for the quantification of JWH 073 N-butanoic acid metabolite by GC- or LC-mass spectrometry (MS). JWH 073 N-butanoic acid metabolite, characterized by carboxylation of the N-alkyl chain, is expected to be a urinary metabolite of JWH 073 based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291}
Brand:CaymanSKU:9000870 - 500 µgAvailable on backorder
JWH 073-d7 (exempt preparation) contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4′ positions. It is intended for use as an internal standard for the quantification of JWH 073 (exempt preparation) by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} Its effects on suppression of spontaneous activity, maximum possible antinociceptive effect in the tail-flick assay, and rectal temperature are comparable to those of WIN 55,212-2 when tested in rats.{16798}
Brand:CaymanSKU:9000868 - 1 mgAvailable on backorder
JWH 073-d7 (exempt preparation) contains seven deuterium atoms at the 2, 2’, 3, 3’, 4, 4, and 4′ positions. It is intended for use as an internal standard for the quantification of JWH 073 (exempt preparation) by GC- or LC-mass spectrometry (MS). JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} Its effects on suppression of spontaneous activity, maximum possible antinociceptive effect in the tail-flick assay, and rectal temperature are comparable to those of WIN 55,212-2 when tested in rats.{16798}
Brand:CaymanSKU:9000868 - 500 µgAvailable on backorder
JWH 080 is a synthetic cannabinoid (CB) which binds both the central CB1 receptor (Ki = 5.6 nM) and the peripheral CB2 receptor (Ki = 2.2 nM) in vitro.{16797} The in vivo physiological and toxicological properties of this compound have not been elucidated. This product is intended for forensic and research applications.
Brand:CaymanSKU:-